Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
166.6 USD | +1.59% | +25.36% | +67.53% |
May. 24 | Novavax awaits FDA decision on whether its next COVID shot can be offered in US | RE |
May. 23 | Global markets live: Anglo American, Nvidia, Apple, Amazon, Tesla, Walt Disney... |
Evolution of the average Target Price on Moderna, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Moderna, Inc.
Evercore ISI | |
Deutsche Bank Securities | |
UBS | |
Jefferies & Co. | |
Oppenheimer | |
Goldman Sachs | |
Leerink Partners | |
Morgan Stanley | |
RBC Capital Markets | |
Redburn | |
HSBC | |
Canaccord Genuity | |
RBC | Luca Issi |
JPMorgan Chase | |
Argus | |
TD Cowen | |
William Blair & Co. | |
Guggenheim | |
SVB Securities LLC | |
Cowen | |
Chardan Research | |
Piper Sandler | |
SVB Leerink | |
BofA Securities | |
Wolfe Research | |
Barclays | |
Chardan | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- MRNA Stock
- Consensus Moderna, Inc.